|
This alleged adverse event report is associated with an ongoing litigation; therefore, attempts to obtain additional information regarding the patient/treatment details/device information are not possible at this time.Although device information was not provided, a review of devices purchased by the treating practice was performed and revealed one ulthera system control unit has been sold to the practice.As this ulthera system control unit is the only device on record in possession by the treating practice, this unit was used to perform an investigation.A review of this control unit's device history record revealed no non-conformances or rework were associated with the manufacture of this device.Three deviations were listed; however, none could have contributed to the reported event and this device passed all required testing prior to distribution.A review of the service history for this control unit revealed this device has not been returned for service since the initial distribution of this device.The patient investigation found that not enough details were provided to confirm whether a merz/ulthera device malfunctioned, and it is not confirmed whether a merz/ulthera device caused or contributed to the event.An analysis of the ultherapy patient complaint trending for the reported issues of fat/volume loss, neuropathy/paresthesia, palsy/paresis, and "patient other" revealed the trend for each reported issue is within allowable limits and will continue to be monitored.An analysis of the ultherapy patient complaint trending analysis for the reported issue of pain revealed a trending limit was exceeded and an investigation is underway for this issue.An analysis of the ultherapy patient complaint trending for the reported issue of vision effects revealed this reported issue has not occurred at a high enough frequency to generate a trend and will continue to be monitored.No additional information is available at this time.If additional information is received, a supplemental medwatch form will be submitted.
|
|
Merz/ulthera received information regarding an ulthera system adverse event via lawsuit on 21-feb-2020.The reporter alleged that she sustained serious injuries as a result of her ulthera treatment performed on (b)(6) 2019.Post treatment, the patient stated that ultherapy caused her severe and permanent facial, eye, and nerve damage, including tingling in the right arm and leg, paresthesia, bilateral uncontrolled hand shaking, facial numbness, facial pain, fat atrophy, increased wrinkles, vision loss, blurred vision, eye hemorrhage, ringing of the ears, light sensitivity, oral dryness and associated mouth and teeth pain, increased skin elasticity, and other painful, disfiguring, debilitating injuries that were not specified.No further information is available at this time.
|